Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12438432 | 0.94 | IGF1R (0.59) | IGF1R | |
| SCHEMBL14162073 | 0.86 | IGF1R (0.58) | IGF1R | |
| SCHEMBL12438434 | 0.85 | IGF1R (0.59) | IGF1R | |
| SCHEMBL12439402 | 0.85 | IGF1R (0.58) | IGF1R | |
| SCHEMBL14050466 | 0.84 | IGF1R (0.60) | IGF1RSLC5A7 | |
| SCHEMBL12438050 | 0.82 | IGF1R (0.62) | IGF1RSLC5A7 | |
| SCHEMBL12439872 | 0.78 | IGF1R (0.58) | IGF1R | |
| SCHEMBL14162069 | 0.78 | IGF1R (0.63) | IGF1R | |
| SCHEMBL12439804 | 0.77 | IGF1R (0.59) | IGF1R | |
| SCHEMBL12437973 | 0.77 | IGF1R (0.60) | IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008076415-A1 | METHODS OF USING MEK INHIBITORS | EXELIXIS, INC. (US) | 2008-06-26 | — | — | WO | disclosed |